Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug combo may prevent worsening after stroke

NCT ID NCT07295366

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 22 times

Summary

This study tested whether giving a powerful cholesterol-lowering drug (evolocumab) within 6 hours after a stroke clot removal procedure could prevent early neurological worsening. 60 adults with large-vessel stroke were randomly assigned to receive either the drug plus standard care or standard care alone. The main goal was to see if the drug reduced the chance of worsening symptoms or death within the first week.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China

Conditions

Explore the condition pages connected to this study.